Hepion Pharmaceuticals, Inc. (HEPA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.27K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.27K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 798.51K | 609.68K | 527.9K | 1.75M | 1.28M | 1.2M | 4.46M | 8.5M | 5.18M | 7.21M | 10.66M | 14.17M | 13.21M | 9.77M | 8.47M | 20M | 7.25M | 9M | 8.52M | 6.85M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 728.51K | 609.68K | 527.9K | 919.49K | 1.26M | 1.79M | 1.7M | 1.37M | 2.64M | 1.76M | 2.15M | 2.28M | 3.41M | 2.26M | 2.73M | 2.43M | 2.94M | 2.09M | 2.72M | 2.67M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 70K | 0 | 0 | 423.28K | 22.23K | -591.61K | 2.76M | 7.14M | 2.54M | 5.44M | 8.52M | 11.88M | 9.8M | 7.52M | 5.74M | 15.7M | 4.31M | 6.91M | 5.8M | 4.19M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 402.75K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | 0 | 0 |
| Operating Income | -798.51K | -609.68K | -527.9K | -1.75M | -1.28M | -1.2M | -4.46M | -8.5M | -5.18M | -7.22M | -10.66M | -14.17M | -13.21M | -9.77M | -8.47M | -20M | -7.25M | -9M | -8.52M | -6.85M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 37.65% | 49.28% | 88.16% | 79.47% | 75.29% | 83.35% | 58.2% | 39.97% | 60.77% | 26.14% | -25.98% | 29.17% | -82.13% | -8.59% | 0.61% | -191.75% | -20.24% | -81.72% | -36.69% | -43.54% |
| EBITDA | -798.51K | -625.06K | -520.21K | -1.74M | -6.08M | 3.23M | -4.46M | -8.5M | -5.15M | -7.21M | -10.65M | -14.15M | -13.19M | -9.75M | -8.45M | -19.98M | -7.23M | -8.98M | -8.49M | -6.83M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 86.87% | -119.35% | 88.33% | 79.56% | -18.04% | 144.82% | 58.12% | 39.89% | 60.95% | 26.12% | -26.02% | 29.19% | -82.46% | -8.67% | 0.55% | -192.39% | -20.23% | -81.74% | -36.48% | -43.31% |
| D&A (Non-Cash Add-back) | 0 | -15.38K | 7.69K | 7.69K | 0 | 0 | 0 | 0 | 30.76K | 12.27K | 18.5K | 18.33K | 18.04K | 18.48K | 17.73K | 18.53K | 22.73K | 23.41K | 23.11K | 21.41K |
| EBIT | -798.51K | -365.21K | -464.39K | -1.34M | -6.08M | 3.23M | -4.46M | -8.5M | -5.82M | -11.47M | -10.66M | -14.17M | -13.26M | -9.77M | -8.47M | -19.91M | -6.93M | -9.73M | -9.27M | -7.66M |
| Net Interest Income | -2.13K | -12.58K | -8.12K | 0 | -24.81K | -817.93K | -474.57K | 49.54K | -4.35K | -2.41K | -2.38K | -2.35K | -2.32K | -2.51K | -2.27K | -3.18K | -2.21K | -2.18K | -2.13K | -2.49K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49.54K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.13K | 12.58K | 8.12K | 0 | 24.81K | 817.93K | 474.57K | 0 | 4.35K | 2.41K | 2.38K | 2.35K | 2.32K | 2.51K | 2.27K | 3.18K | 2.21K | 2.18K | 2.13K | 2.49K |
| Other Income/Expense | -12.28K | -47.2K | 55.4K | 702.94K | -4.83M | -345.3K | -407.69K | 4.58M | -640.74K | -4.25M | 137.62K | 86.08K | -50.76K | 77.49K | -82.27K | 86.82K | 322.78K | -733.09K | -752.12K | -812.51K |
| Pretax Income | -810.79K | -656.88K | -472.51K | -1.04M | -6.11M | -1.55M | -4.87M | -3.93M | -5.82M | -11.47M | -10.53M | -14.08M | -13.26M | -9.7M | -8.55M | -19.91M | -6.93M | -9.73M | -9.27M | -7.67M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.97M | -409.02K | 0 | 0 | 0 | -2.88M | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 50.99% | 3.57% | 0% | 0% | 0% | 29.74% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -810.79K | -656.88K | -472.51K | -1.04M | -6.11M | -1.55M | -4.87M | -3.93M | -2.85M | -11.06M | -10.53M | -14.08M | -13.26M | -6.81M | -8.55M | -19.91M | -6.93M | -9.73M | -9.27M | -7.67M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 86.72% | 57.55% | 90.29% | 73.44% | -113.96% | 86.01% | 53.78% | 72.12% | 78.48% | -62.37% | -23.16% | 29.29% | -91.35% | 30.02% | 7.79% | -159.7% | -14.28% | -96.4% | -48.75% | -55.2% |
| Net Income (Continuing) | -810.79K | -656.88K | -472.51K | -1.04M | -6.11M | -1.55M | -4.87M | -3.93M | -2.85M | -11.06M | -10.53M | -14.08M | -13.26M | -6.81M | -8.55M | -19.91M | -6.93M | -9.73M | -9.27M | -7.67M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.07 | -0.06 | -0.04 | -0.09 | -2.15 | -11.12 | -36.21 | -33.84 | -28.13 | -121.15 | -137.13 | -183.97 | -173.95 | -130.51 | -112.13 | -261.20 | -90.91 | -127.61 | -121.58 | -100.56 |
| EPS Growth % | 96.74% | 99.49% | 99.89% | 99.73% | 92.36% | 90.82% | 73.59% | 81.6% | 83.83% | 7.17% | -22.3% | 29.57% | -91.34% | -2.27% | 7.77% | -159.75% | 21.78% | 17.53% | 82.41% | 82.71% |
| EPS (Basic) | -0.07 | -0.06 | -0.04 | -0.09 | -2.15 | -11.12 | -36.21 | -33.84 | -28.13 | -121.15 | -137.13 | -183.97 | -173.95 | -130.51 | -112.13 | -261.20 | -90.91 | -127.61 | -121.58 | -100.56 |
| Diluted Shares Outstanding | 11.62M | 9.41M | 11.62M | 11.33M | 2.84M | 139.17K | 134.38K | 115.98K | 101.45K | 91.29K | 76.77K | 76.53K | 76.23K | 76.23K | 76.23K | 76.23K | 76.23K | 76.22K | 76.22K | 76.22K |
| Basic Shares Outstanding | 11.62M | 9.41M | 11.62M | 11.33M | 2.84M | 139.17K | 134.38K | 115.98K | 101.45K | 91.29K | 76.77K | 76.53K | 76.23K | 76.23K | 76.23K | 76.23K | 76.23K | 76.22K | 76.22K | 76.22K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |